DRI vs ZYME · P/E 22, rev $12.08B vs rev $76.3M
Darden Restaurants Inc (DRI) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the DRI and ZYME stock pages for the full models.
Not investment advice.